Hematology TimesALF 2019 showcases evolving treatment of AMLApril 19, 2019AMLLeukemia, Myelodysplasia, TransplantationTransplantationTransplant
Hematology NewsInfant survival rate after HCT remains flatMarch 18, 2019TransplantationCellular Therapy
Hematology NewsMRD status at transplant predicts outcomes in ALL patientsMarch 14, 2019TransplantationALLLeukemia, Myelodysplasia, TransplantationCellular Therapy
Hematology NewsSecondary AML in first remission predicts outcomesMarch 14, 2019TransplantationLeukemia, Myelodysplasia, TransplantationAMLCellular Therapy
Hematology NewsHaplo-HSCT bests chemotherapy for MRD-positive adult ALLMarch 13, 2019TransplantationALLLeukemia, Myelodysplasia, TransplantationCellular Therapy
Hematology NewsTherapeutic dosing of busulfan helps reduce relapse in ASCTMarch 13, 2019TransplantationAggressive LymphomasLymphoma & Plasma Cell DisordersCellular Therapy
Hematology NewsAnti-CD45 conditioning looks safe, feasible in relapsed AMLMarch 13, 2019TransplantationAMLLeukemia, Myelodysplasia, TransplantationCellular Therapy
Hematology NewsWeak evidence surrounds use of mesenchymal stem cellsMarch 12, 2019TransplantationCellular Therapy
Hematology NewsEngraftment achieved after conditioning without radiation, alkylating agentsMarch 7, 2019TransplantationCellular Therapy
Hematology TimesKD025 produces durable responses in patients with cGVHDMarch 7, 2019TransplantationPatient & Survivor CareCellular Therapy
Hematology NewsLentiviral gene therapy appears effective in X-CGDMarch 6, 2019TransplantationRare DiseasesCellular TherapyGene Therapy
Hematology NewsNovel transplant regimen improves survival in primary immunodeficiencyMarch 6, 2019TransplantationCellular TherapyTransfusion Medicine
Hematology NewsIxazomib targets treatment failure in chronic GVHDMarch 6, 2019TransplantationCellular Therapy
Hematology NewsPost-HCT azithromycin doesn’t increase relapse risk, study suggestsMarch 3, 2019Leukemia, Myelodysplasia, TransplantationTransplantation
Hematology NewsCLL, GVHD may raise risk for skin cancer after allo-HCTFebruary 28, 2019CLLTransplantationNonmelanoma Skin CancerLeukemia, Myelodysplasia, TransplantationCellular Therapy
